An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC)
Clinical trial NCT02305615 · COMPLETED
Trial details
- NCT number
- NCT02305615
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-01-13
- Primary completion
- 2017-12-29
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.